Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• G-protein-coupled receptors (GPCRs) are crucial drug targets, and their activation by ligands is key to physiological responses.
• Ligand efficacy, defined by the stabilization of active receptor states (R*), dictates the magnitude of a drug's effect.
• Quantifying GPCR ligand efficacy traditionally involves complex cell-based assays and indirect measurements.

Purpose of the Study:

• To develop a direct, cell-free method for quantifying the intrinsic efficacy of orthosteric ligands at GPCRs.
• To characterize the distinct active receptor states (R*) stabilized by different ligands using a novel biosensor approach.
• To demonstrate the applicability of this technique to various GPCRs, including the mu-opioid receptor (µ-OR).

Main Methods:

• Developed a R*-specific biosensor (nanobody-39, Nb39) for detecting active µ-OR.
• Employed interferometry to directly measure the binding of Nb39 to purified µ-OR in the presence of various ligands.
• Validated the method using known µ-OR ligands (methadone, loperamide, PZM21) and positive allosteric modulators, and tested its compatibility with heterotrimeric G protein.

Main Results:

• Demonstrated that different ligands exhibit varying abilities to recruit the Nb39 biosensor to the µ-OR, reflecting differential stabilization of active states.
• Identified specific active receptor conformations (R*) supported by methadone, loperamide, and PZM21.
• Showed that positive allosteric modulators enhance R* formation, and the technique is functional with heterotrimeric G protein.

Conclusions:

• The developed interferometry-based biosensor assay provides a direct and quantitative measure of ligand efficacy at GPCRs.
• This cell-free, signal transduction-independent method is broadly applicable to diverse GPCRs and offers insights into ligand-specific active state stabilization.
• The technique facilitates a deeper understanding of GPCR pharmacology and drug action.